Replies to post #1442 on Emergent Health Corp (EMGE)

[Invest-in-America]

EMGE: I just today also spotted that (excellent) "MicroCapDaily" article, a LINK to which I have RE-posted here for any interested parties.
https://microcapdaily.com/emergent-health-otcmkts-emge-big-week-as-rm-runner-closes-on-acquisitions-and-looks-to-go-fully-reporting/

"Emergent Health (OTCMKTS: EMGE) continues to make steady gains up the charts in recent trading running all of last week and closing the week off strong up 25% on Friday on $1 million in dollar volume. The stock is under heavy accumulation and is quickly turning into one of the top most searched for stocks on the OTC. Blessed with a tight share structure EMGE is one reverse merger that has not disappointed so far and has a lot of room to grow. EMGE is now closing on the acquisition of Regen Biowellness, Inc.". (Quoted in part; emphases added.)

///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

[crudeoil24]

"Emergent Health (OTCMKTS: EMGE) continues to make steady gains up the charts in recent trading running all of last week and closing the week off strong up 25% on Friday on $1 million in dollar volume. The stock is under heavy accumulation and is quickly turning into one of the top most searched for stocks on the OTC. Blessed with a tight share structure EMGE is one reverse merger that has not disappointed so far and has a lot of room to grow. EMGE is now closing on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields and bringing on executive Jim Morrison, the former president of L’Oréal as the new CEO of Emergent upon the acquisition of Evolutionary Biologics, expected to close within the next three weeks. Emergent plans to create a complete human and pet portfolio and become a major participant in the field of OTC human and pet products. Fusion Specialty Pharmacy is a nationally accredited compounding pharmacy licensed in 27 states and located in St. George, Utah dedicated to formulating creative, individualized, and compounded medications. Fusion generated $3,801,497 in 2021 Revenues, an approximate 100% increase from 2020 Revenues of $1,971,599. New CEO Jim Morrison has big plans for Emergent including continued growth through acquisition, becoming fully reporting and uplisting to the big boards. "